X-78012985-A-G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PP3_ModerateBP6BS2

The NM_000052.7(ATP7A):​c.2279A>G​(p.Tyr760Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,208,816 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000019 ( 0 hom. 8 hem. )

Consequence

ATP7A
NM_000052.7 missense

Scores

13
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:2

Conservation

PhyloP100: 9.32

Publications

3 publications found
Variant links:
Genes affected
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to phosphoglycerate kinase 1 deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.886
BP6
Variant X-78012985-A-G is Benign according to our data. Variant chrX-78012985-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 533671.
BS2
High AC in GnomAdExome4 at 21 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000052.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7A
NM_000052.7
MANE Select
c.2279A>Gp.Tyr760Cys
missense
Exon 10 of 23NP_000043.4
ATP7A
NM_001282224.2
c.2172+1311A>G
intron
N/ANP_001269153.1
ATP7A
NR_104109.2
n.285-18415A>G
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7A
ENST00000341514.11
TSL:1 MANE Select
c.2279A>Gp.Tyr760Cys
missense
Exon 10 of 23ENSP00000345728.6
ATP7A
ENST00000689767.1
c.2372A>Gp.Tyr791Cys
missense
Exon 12 of 25ENSP00000509406.1
ATP7A
ENST00000343533.10
TSL:5
c.2309A>Gp.Tyr770Cys
missense
Exon 11 of 24ENSP00000343026.6

Frequencies

GnomAD3 genomes
AF:
0.00000898
AC:
1
AN:
111297
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000378
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000599
AC:
11
AN:
183490
AF XY:
0.0000442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00107
Gnomad EAS exome
AF:
0.000216
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000191
AC:
21
AN:
1097519
Hom.:
0
Cov.:
31
AF XY:
0.0000220
AC XY:
8
AN XY:
362897
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26389
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.000568
AC:
11
AN:
19379
East Asian (EAS)
AF:
0.0000993
AC:
3
AN:
30198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54135
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40532
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
0.00000713
AC:
6
AN:
841477
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000898
AC:
1
AN:
111297
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33483
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30598
American (AMR)
AF:
0.00
AC:
0
AN:
10350
Ashkenazi Jewish (ASJ)
AF:
0.000378
AC:
1
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3569
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2679
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5941
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53099
Other (OTH)
AF:
0.00
AC:
0
AN:
1492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.0000151
ExAC
AF:
0.0000330
AC:
4

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Menkes kinky-hair syndrome;C0268353:Cutis laxa, X-linked;C1845359:X-linked distal spinal muscular atrophy type 3 (2)
-
2
-
not provided (2)
-
-
1
Inborn genetic diseases (1)
1
-
-
X-linked distal spinal muscular atrophy type 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.80
BayesDel_addAF
Pathogenic
0.54
D
BayesDel_noAF
Pathogenic
0.83
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.84
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.91
D
MetaRNN
Pathogenic
0.89
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.3
H
PhyloP100
9.3
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-8.3
D
REVEL
Pathogenic
0.90
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.94
MutPred
0.44
Loss of glycosylation at S761 (P = 0.1587)
MVP
1.0
MPC
0.94
ClinPred
0.99
D
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.37
gMVP
0.93
Mutation Taster
=13/87
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782006661; hg19: chrX-77268482; API